VPAG 2026 - Life Science Access Academy

Expert insights on pricing, access and policy changes shaping the year ahead

Masterclass Details:

As the new NHS fiscal year approaches, the next phase of the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) is set to reshape the commercial landscape once again. Adjustments to payment percentages, growth limits and exemption thresholds will come into force from April, with direct implications for pricing strategy, access planning and NHS collaboration with industry.

In this 60-minute masterclass, our expert panel will discuss what’s changing for 2026 and what these adjustments mean in practice.

Our panel will also reflect on lessons from 2025, revealing how VPAG continues to influence branded medicines pricing, affordability and future innovation funding. Gain clarity on the upcoming financial and policy shifts, to prepare for the year ahead with confidence and insight.

Join live to hear directly from policy and market access leaders and ask your questions.

Key Learning Objectives:

Review VPAG’s impact on pricing, access and NHS financial priorities in 2025
Understand the updated payment percentages, growth allowances and exemption thresholds for 2026
Assess how these changes affect branded medicine pricing and company strategy
Explore opportunities for proactive engagement and compliance under the current framework
Learn how to align organisational plans with NHS objectives and fiscal expectations

LSAA reserves the right to restrict access to this webinar to LSAA members.

Date and time

23rd Mar 2026 13:00 – 14:00 (GMT)

VPAG 2026

Speakers

Client feedback

Marsha Gray, Training Specialist

Boehringer Ingelheim Ltd

“Working with Life Science Access Academy, our company love the variety of the many courses that are on offer. The hour long courses on specific subjects are really useful on Friday lunchtimes for our field teams and gain a lot of interest.

Life Science Access Academy are also super flexible and helpful when it comes to tailoring some additional sessions to our needs.”

Paul Runeckles, Director of Execution Excellence

Ferring

“We have been partnered with LSAA for several years now which has enabled our team members to develop their competencies and capabilities.

With over 700 learning modules, regular webinars on highly relevant topics across the UK, the opportunity to engage with expert speakers after events and regular blogs and newsletters, the platform is a highly valued resource at Ferring.

The team also provides regular usage statistics so we can understand the hot topics in Ferring and enable colleagues to share knowledge and experience with each other.”

Simon Warden, National Sales Manager

Frontier Medical Group

“Frontier Medical has fully implemented, Life Science Access Academy allowing Sales and Marketing to utilise the system. Maximising on line learning for all remote staff stimulates a culture of self-development giving individuals the accountability and responsibility to broaden their skills set.

Life Science Access Academy training is topical and a good fit for the fast paced healthcare market.”

Richard Edmonds

Gedeon Richter Women's Health

“I have found the training via the Life Science Access Academy to be excellent and I know many of my colleagues have as well.

The content is always kept up to date and there is a huge and interesting variety of topics covered. The site is curated in a way that makes it clear and easy to navigate. Also, the staff at Life Science Access Academy are friendly and responsive and all the experts are always knowledgeable in their areas.”

Robb Sayers, UK Capability Lead

ViiV Healthcare

“The variety and relevancy of content brings value to many different roles across the healthcare industry.

I have also been overwhelmed by the way the Life Science Access Academy team have accommodated our own business needs, being sensitive yet responsive to helping us since its formation.”